Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.64 No.2

Vol.64 No.2 contents

Invited Review

Clinical features and pathogenesis of Glial fibrillary acidic protein (GFAP) antibodyassociated disorders

Akio Kimura, M.D., PhD.

CLINICA NEUROL, 64: 75−84, 2024


Central nervous system disorders secondary to histiocytoses: neurodegeneration with potential for improvement

Akira Morimoto, M.D., Ph.D. 1), Kenichi Sakamoto, M.D., Ph.D. 2), Ko Kudo, M.D. 3) and Yoko Shioda, M.D., Ph.D. 4)

CLINICA NEUROL, 64: 85−92, 2024

Case Report

Embolic stroke due to ascending aortic thrombus in a patient with treatment-resistant ulcerative colitis

Kenichi Inoue, M.D. 1), Toshiyasu Ogata, M.D. 1), Takayasu Mishima, M.D. 1), Hideki Ishibashi, M.D. 2), Fumihito Hirai, M.D., Ph.D. 2) and Yoshio Tsuboi, M.D., Ph.D. 1)

CLINICA NEUROL, 64: 93−98, 2024

Case Report

A case of Alice in Wonderland syndrome after Epstein-Barr virus (EBV) encephalitis: a mimicry of focal epileptic seizure

Kyoko Hosokawa, M.D. 1)2), Kazuki Oi, M.D., Ph.D. 1)3), Takefumi Hitomi, M.D., Ph.D. 4), Takahiro Mitsueda, M.D., Ph.D. 5), Tomokazu Nakagawa, M.D., Ph.D. 6)7) and Akio Ikeda, M.D., Ph.D. 8)

CLINICA NEUROL, 64: 99−104, 2024

Case Report

A case of spinal cord infarction presenting with unilateral C5 palsy

Tatsuki Matsuda, M.D.1), Takahiko Taniguchi, M.D.1), Misaki Hanya, M.D.1), Keisuke Kitani, M.D.1), Hisashi Takahashi, M.D.1)* and Takashi Kasai, M.D., Ph.D.2)

CLINICA NEUROL, 64: 105−108, 2024

Case Report

Eculizumab led to beneficial clinical course in a patient with generalized myasthenia gravis who developed COVID 19-associated pneumonia

Yusuke Kuroda, M.D. 1)2), Gennya Watanabe, M.D. 1), Kazuki Satou, M.D. 2), Hirohiko Ono, M.D., Ph.D. 2), Kennichi Tsukita, M.D. 1) and Yasushi Suzuki, M.D., Ph.D. 1)

CLINICA NEUROL, 64: 109−112, 2024

Brief Clinical Note

Clinical features and effects of shunt surgery in patients with progressive supranuclear palsy and idiopathic normal pressure hydrocephalus

Naoki Yamahara, M.D., Nobuaki Yoshikura, M.D., Ph.D. and Takayoshi Shimohata, M.D., Ph.D.

CLINICA NEUROL, 64: 113−116, 2024

Facility introduction

CLINICA NEUROL, 64: 117−118, 2024

Notice for Members

CLINICA NEUROL, 64: 119−124, 2024

Notice for Members

CLINICA NEUROL, 64: 125−125, 2024


CLINICA NEUROL, 64: 126−131, 2024

Editor's Note

CLINICA NEUROL, 64: 132−132, 2024